SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001867929-21-000001
Filing Date
2021-06-22
Accepted
2021-06-22 17:24:16
Documents
1
Effectiveness Date
2021-06-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8411
  Complete submission text file 0001867929-21-000001.txt   9493
Mailing Address 6100 ROYAL MOUNT AVENUE NRC BUILDING MONTREAL A8 H4P2R2
Business Address 6100 ROYALMOUNT AVENUE NRC BUILDING MONTREAL A8 H4P2R2 (416) 697-9212
Kalgene Phamaceuticals Inc. (Filer) CIK: 0001867929 (see all company filings)

IRS No.: 830005526 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-403855 | Film No.: 211036340